Bioclinica is the leader in scientifically-driven services and technology-enabled solutions in clinical research.
Clinical trials are complex, and traditional approaches are either monolithic or fragmented. Successful trials require an ability to see key details and uncover hidden insights. Employing our scientifically-driven and technology-enabled approach, Bioclinica brings CLARITY to clinical trials for better decisions. With such clarity comes the insight to help trial sponsors and Clinical Research Organizations (CROs) develop new life-improving therapies more efficiently and safely _ and with improved quality outcomes.
Our scientific, medical, technology and domain expertise is unmatched and spans all major therapeutic areas _ and the full trial lifecycle, from study protocol, to post-approval. Key offerings include: Medical imaging; Cardiac Safety; Clinical Adjudication; Randomization & Trial Supply Management and Optimization; Electronic and eSource Data Capture; Site Payments and Forecasting; Pharmacovigilance; Trial Management; and Risk-based Monitoring. Additionally, as a true multifaceted partner to trial sponsors and CROs, Bioclinica offers an integrated App xChange partner ecosystem, a global Research Network of investigative sites, Patient Recruitment and Lost to Follow-up Services, and Post-approval Research expertise.
Bioclinica and our thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations Ð including all of the top 20 biopharmaceutical companies and leading CROs Ð through a network of offices in the U.S., Europe, and Asia. Learn more about our complete offerings, detail-focused service, and flexible models tailored to your business needs at www.Bioclinica.com.
- Company Name:Bioclinica
(View Trends)
-
Headquarters: (View Map)Newtown, PA, United States
-
Pharmaceuticals
-
1,000 - 5,000 employees
- 367356 Global Rank
- 160860 United States
- 226 K Estimated Visits
-
Direct73.72%
-
Search13.76%
-
Referrals5.12%
-
Social4.56%
-
Mail2.43%
-
Display0.39%
-
28.72%
-
19.64%
-
14.88%
-
13.22%
- United States 88.9%
- India 8.9%
- Labels
- Sony BMG
- 0 SDKs
- 0 Total reviews
- App Url: https://itunes.apple.com/app/transenda/id534611331
- App Support: http://www.bioclinica.com/Support/training/
- Genre: Medical
- Bundle ID: com.bioclinica.RECIST.1.0vs1.1
- App Size: 48.7 M
- Version: 1.1
- Release Date: June 21st, 2012
- Update Date: August 14th, 2012
Description:
BioClinica's "Interactive RECIST Training Program" is an excellent learning technique that will guide the user through the criteria and its classifications on response for solid tumors.
RECIST (Response Evaluation Criteria in Solid Tumors) was originally published in 2000 as version 1.0. An update 1.1 was released in January 2009 by an international collaborative group involved in cancer research. Numerous clinical trials, both past and present, use these criteria to evaluate solid tumor response in the drug development process.
It will describe the major differences between the RECIST versions 1.0 and 1.1.
-
Standard0%
They are headquartered at Newtown, PA, United States, and have 3 advertising & marketing contacts listed on Kochava. Bioclinica works with Advertising technology companies such as Videology, The Trade Desk, Chango, Neustar AdAdvisor, Dstillery, Turn, DemDex, AOL-Time Warner Online Advertising, BlueKai, Atlas, Resonate Insights, DoubleClick.Net, AppNexus, Yahoo Small Business, Facebook Exchange FBX, AppNexus Segment Pixel, BlueKai DMP, Google Remarketing, DoubleClick Bid Manager, Pubmatic, Rubicon Project, eXelate, Aggregate Knowledge, Semasio, Eyeota, Drawbridge, IntentIQ, LinkedIn Ads.